US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (232)
  • Diseases & Conditions (4574)
  • Drug Delivery (190)
  • Therapeutic Area (7211)
  • Vaccines (655)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
6/19/2015 | published by: Kalorama Information
... in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or ...  |  read more...
USD 4,200
Riyadh Pharma Medical & Cosmetic Products Co Ltd in Consumer Health (United Arab Emirates)
6/9/2015 | published by: Euromonitor International
... OTC products; a category in which the company has a presence in the Kingdom of Saudi Arabia, but holds a very small presence outside the country’s borders. It is likely that the company will invest ...  |  read more...
USD 572
Amway India Enterprises Pvt Ltd in Consumer Health (India)
6/15/2015 | published by: Euromonitor International
... chief executive officer. As a result of which the company lost some ground. The company plans to concentrate on rebuilding its brand name over the forecast period, in order to become the leading direct selling ...  |  read more...
USD 572
Aspen Pharmacare Australia Pty Ltd in Consumer Health (Australia)
6/15/2015 | published by: Euromonitor International
... overlooked by the multinational pharmaceutical companies. The company is also seeking to achieve a strategic advantage through its production capability, by consolidating its manufacturing sites. Euromonitor International Local Company Profiles are a concise set of ...  |  read more...
USD 572
Biofarm SA in Consumer Health (Romania)
6/17/2015 | published by: Euromonitor International
... development, while also remaining a main producer of consumer health products. The company retained its leading position in digestive remedies and nasal decongestant drops. The company also invests in strengthening its position outside Romania, by ...  |  read more...
USD 572
CJ Olive Young Corp in Consumer Health (South Korea)
6/19/2015 | published by: Euromonitor International
... in beauty care, health care, personal care, packaged food and personal goods. Beauty care products account for 50% of total sales in 2014, but the company plans to focus on packaged food and health care ...  |  read more...
USD 572
Emami Ltd in Consumer Health (India)
6/15/2015 | published by: Euromonitor International
... well. The company plans to continue to maintain its leadership with the help of its flagship brands, and the launch of new affordable and quality fast moving consumer good products. Euromonitor International Local Company Profiles ...  |  read more...
USD 572
Korea Ginseng Corp in Consumer Health (South Korea)
6/19/2015 | published by: Euromonitor International
... has a wide distribution network in all provinces of South Korea. The company plans to strengthen its exports to China, Japan and Southeast Asian countries with active marketing strategies over the forecast period. Korea Ginseng ...  |  read more...
USD 572
Kwang Dong Pharm Co Ltd in Consumer Health (South Korea)
6/19/2015 | published by: Euromonitor International
... of non-alcoholic drink products by using existing networks and developing consumer marketing activities. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact ...  |  read more...
USD 572
My Chemist Group in Consumer Health (Australia)
6/15/2015 | published by: Euromonitor International
... to traditional pharmacies led to soaring growth in recent years. It typically locates its outlets in redundant retail spaces with lower rents, and adopts an aggressive pricing policy, with a wide range of OTC products. ...  |  read more...
USD 572
Pharmacare Laboratories Pty Ltd in Consumer Health (Australia)
6/15/2015 | published by: Euromonitor International
... or widening its distribution channels. Pharmacare’s brand portfolio includes Nature’s Way, KP 24, Bioglan and Fat Blaster. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a ...  |  read more...
USD 572
Red Seal Natural Health Ltd in Consumer Health (New Zealand)
6/15/2015 | published by: Euromonitor International
... well as developing its export capabilities and accessing new international markets. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the ...  |  read more...
USD 572
Vitaco Health NZ Ltd in Consumer Health (New Zealand)
6/15/2015 | published by: Euromonitor International
... Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles. Product coverage: ...  |  read more...
USD 572
Global Colorectal Cancer Drugs Market 2015-2019
6/17/2015 | published by: TechNavio - Infiniti Research Ltd.
... most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common ...  |  read more...
USD 3,000
Belarus Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... to behurt by these factors. We expect the Belarusian government to increase its focus on import substitutiongiven its balance of payments crisis, with negative implications for the pharmaceutical sector. Headline Expenditure Projections Pharmaceuticals: BYR10,223bn in ...  |  read more...
USD 1,295
Global and Chinese Spirulina Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... with a focus on the Chinese market. The report provides key statistics on the market status of the Spirulina manufacturers and is a valuable source of guidance and direction for companies and individuals interested in ...  |  read more...
USD 3,000
Global and Chinese Enteral Feeding Pump Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... the global Enteral Feeding Pump industry with a focus on the Chinese market. The report provides key statistics on the market status of the Enteral Feeding Pump manufacturers and is a valuable source of guidance ...  |  read more...
USD 3,000
Global and Chinese Betamethasone 21-Phosphate Disodium (CAS 151-73-5) Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... state of the global Betamethasone 21-Phosphate Disodium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Betamethasone 21-Phosphate Disodium manufacturers and is a valuable source ...  |  read more...
USD 3,000
Global and Chinese Betamethasone Dipropionate (CAS 5593-20-4) Industry, 2015 Market Research Report
6/17/2015 | published by: Prof-Research
... the global Betamethasone Dipropionate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Betamethasone Dipropionate manufacturers and is a valuable source of guidance and direction ...  |  read more...
USD 3,000
Czech Republic Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... Exports are to see a rise in demand from tradingpartners based on our expectation of increasing generic penetration throughout Europe and demand forgenerics in general across emerging markets. We expect imports to be boosted by ...  |  read more...
USD 1,295
India Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... is driven by the low levels ofhealthcare funding provided by the government as it seeks to reduce budget deficit and prioritise othersectors such as infrastructure. Moreover, we highlight that improvements in healthcare access from theprogramme ...  |  read more...
USD 1,295
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... abroad. Over the long-term, domesticmanufacturers will increase their market share, with the government placing an increasing emphasis onachieving self-sufficiency in terms of pharmaceutical production. Headline Expenditure Projections Pharmaceuticals: SDG2.35bn (USD402mn) in 2014 to SDG2.65bn (USD433mn) ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... spending, for future business expansion potentialsto be met there needs to be a focus upon evolving current healthcare services while also containing costs. On a pharmaceutical front, this evolution needs to take place through the ...  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... access through stronger medicalsubsidies and an expansion of insurance coverage. In addition, reforms in the pharmaceutical sector,including the removal of price caps, will shift the industry towards a market-based system that furtheraugments the commercial prospects. ...  |  read more...
USD 1,295
Cuba Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... cooperation with the island's pharmaceutical sector andJapanese investment in Cuba's healthcare system underscore the significant progress Cuba has achieved inrecent years. Therefore, Cuba will continue to offer unique commercial opportunities to foreign companieswho will benefit ...  |  read more...
USD 1,295
< prev 1    3  4  5  6  7  8  9  10